Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus

BACKGROUND: Bronchiolitis caused by the respiratory syncytial virus (RSV) in infants less than two years old is a growing public health concern worldwide, and there is currently no safe and effective vaccine. A major component of RSV nucleocapsid, the nucleoprotein (N), has been so far poorly explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Roux, Xavier, Dubuquoy, Catherine, Durand, Guillaume, Tran-Tolla, Thi-Lan, Castagné, Nathalie, Bernard, Julie, Petit-Camurdan, Agnès, Eléouët, Jean-François, Riffault, Sabine
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262139/
https://www.ncbi.nlm.nih.gov/pubmed/18335041
http://dx.doi.org/10.1371/journal.pone.0001766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262139/
https://www.ncbi.nlm.nih.gov/pubmed/18335041
http://dx.doi.org/10.1371/journal.pone.0001766

Ejemplares similares